Clearside Biomedical Inc CLSDQ
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 5.23M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.39
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 32
- Website
- https://www.clearsidebio.com
Valuation
|
Metric
|
CLSDQ
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.39 |
Price/Cash Flow | — |
Price/Earnings
CLSDQ
Financial Strength
|
Metric
|
CLSDQ
|
|---|---|
Quick Ratio | 2.55 |
Current Ratio | 2.98 |
Interest Coverage | −1.45 |
Quick Ratio
CLSDQ
Profitability
|
Metric
|
CLSDQ
|
|---|---|
Return on Assets (Normalized) | −149.78% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
CLSDQ
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|n<KpGs | LOCK|<#bn | $133B | |||
| Moderna Inc
MRNA
| LOCK|$lT$XM | LOCK|>%@ | $98B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|%tBz?> | LOCK|Nv?@ | $83B | |||
| argenx SE ADR
ARGX
| LOCK|B!<<LLm | LOCK|>< | $56B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|wLCG@Bt | LOCK|>> | $45B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|%@S>sH | LOCK|R>%< | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|rxZx!$v | LOCK|>XD#j | $28B | |||
| Incyte Corp
INCY
| LOCK|x&%<wbN | LOCK|##l | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|BnS!p@T | LOCK|G#r | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|J!k^YZ | LOCK|&j | $14B |
United States